European Archives - Page 696 of 1392 - European Medical Journal

Infographic: 5 Key Reasons: All Infants Need Protection from RSV

Infographic: 5 Key Reasons: All Infants Need Protection from RSV. This educational activity is sponsored by Sanofi.

Medical affairs, AI and insight generation

AI holds buckets of potential for medical affairs teams, but it must be adopted considerately and correctly to meet their needs.

Super reps, ChatGPT and pharma’s future on social media

Isabel chats to Darshan Kulkarni, regulatory and compliance attorney for the Life Sciences, about key marketing and medical affairs trends.

Unexplained Renal Impairment in a Patient With Seminoma

Testicular seminomas are the most common type of testicular germ cell tumours. It typically affects young males between the ages of 30–55 years. Because of its high sensitivity to chemotherapy and radiotherapy, these tumours have high cure rates.

Editor’s Pick – Utility of Bedside Lung Ultrasound in Patients on Chronic Haemodialysis

Estimation of reliable and reproducible dry weight in patients with end-stage renal disease on haemodialysis (HD) is a clinical challenge to date.

Benzodiazepines in Dementia: Review of Clinical Evidence

In the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), Alzheimer’s disease (AD [named after the German psychiatrist and neuropathologist, Alois Alzheimer, who first described it]), is considered as a major or mild neuro-cognitive disorder…

Engineering the Future of Surgery

Monica Jain and Jonathan discuss innovation and biomedical engineering in healthcare and surgery.

EMJ Cardiology 11 [Supplement 1] 2023

Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.

Hearts are NOT Made to Be Broken: Expert Opinion on Amyloid Light-Chain Cardiac Amyloidosis

Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.

Upgrading the personal touch in CX

Pharma’s approach to customer experience could be improved with humanisation of digital touchpoints.